Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5201258
Max Phase: Preclinical
Molecular Formula: C30H47N3O3
Molecular Weight: 497.72
Associated Items:
ID: ALA5201258
Max Phase: Preclinical
Molecular Formula: C30H47N3O3
Molecular Weight: 497.72
Associated Items:
Canonical SMILES: CC(C)CCC[C@@H](C)[C@H]1CC[C@@H]2[C@]1(C)CCC1[C@]23C=C[C@]2(C[C@@H](O)CC[C@]12C)n1c(=O)n(C)c(=O)n13
Standard InChI: InChI=1S/C30H47N3O3/c1-19(2)8-7-9-20(3)22-10-11-23-27(22,4)14-13-24-28(5)15-12-21(34)18-29(28)16-17-30(23,24)33-26(36)31(6)25(35)32(29)33/h16-17,19-24,34H,7-15,18H2,1-6H3/t20-,21+,22-,23-,24?,27-,28-,29-,30+/m1/s1
Standard InChI Key: JSGDDTNEBHLDPF-OSUFGNAPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 497.72 | Molecular Weight (Monoisotopic): 497.3617 | AlogP: 4.78 | #Rotatable Bonds: 5 |
Polar Surface Area: 69.16 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 5.52 | CX LogD: 5.52 |
Aromatic Rings: 1 | Heavy Atoms: 36 | QED Weighted: 0.60 | Np Likeness Score: 1.73 |
1. Khazan N, Kim KK, Hansen JN, Singh NA, Moore T, Snyder CWA, Pandita R, Strawderman M, Fujihara M, Takamura Y, Jian Y, Battaglia N, Yano N, Teramoto Y, Arnold LA, Hopson R, Kishor K, Nayak S, Ojha D, Sharon A, Ashton JM, Wang J, Milano MT, Miyamoto H, Linehan DC, Gerber SA, Kawar N, Singh AP, Tabdanov ED, Dokholyan NV, Kakuta H, Jurutka PW, Schor NF, Rowswell-Turner RB, Singh RK, Moore RG.. (2022) Identification of a Vitamin-D Receptor Antagonist, MeTC7, which Inhibits the Growth of Xenograft and Transgenic Tumors In Vivo., 65 (8.0): [PMID:35404047] [10.1021/acs.jmedchem.1c01878] |
Source(1):